BiomX Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PHGE?
Owner TypeNumber of SharesOwnership Percentage
Private Companies510,2052.81%
Individual Insiders673,3763.7%
VC/PE Firms1,787,7679.84%
Hedge Funds3,518,21019.4%
Institutions5,451,27530%
General Public6,235,76934.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 295.4%.


Top Shareholders

Top 25 shareholders own 65.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.84%
OrbiMed Advisors LLC
1,787,767US$1.6m29.8%0.02%
9.83%
Deerfield Management Company, L.P. Series C
1,787,610US$1.6m193%0.03%
9.52%
Nantahala Capital Management, LLC
1,730,600US$1.6m0%0.11%
5.13%
Cystic Fibrosis Foundation, Endowment Arm
933,058US$851.9k0%100.0%
4.91%
Ikarian Capital, LLC
893,000US$815.3k0%0.24%
4.82%
AMR Action Fund GP, LLC
876,888US$800.6k187%no data
4.76%
Aigh Capital Management, LLC
865,400US$790.1k0%0.34%
3.24%
Heights Capital Management, Inc.
589,027US$537.8k0%0.16%
3.08%
Rodney Hodges
560,267US$511.5k97.3%no data
2.81%
Nimble Ventures, LLC
510,205US$465.8k0%no data
2.38%
ADAR1 Capital Management, LLC
432,700US$395.1k0%0.08%
2.21%
Dafna Capital Management, LLC
401,136US$366.2k0%0.1%
1.31%
Boothbay Fund Management, LLC
237,400US$216.7k0%0.01%
1.06%
Johnson & Johnson Innovation - JJDC, Inc.
192,321US$175.6k0%0.05%
0.29%
Jonathan Solomon
53,056US$48.4k2,020%no data
0.17%
Merav Bassan
31,749US$29.0k0%no data
0.14%
Assaf Oron
25,804US$23.6k0%no data
0.14%
Barclays PLC Private Banking & Investment Banking Investment
25,000US$22.8k0%no data
0.021%
UBS Asset Management AG
3,785US$3.5k-22.4%no data
0.0069%
Lynne Sullivan
1,250US$1.1k0%no data
0.0061%
Clear Street Llc, Asset Management Arm
1,101US$1.0k0%no data
0.0027%
Alan Moses
500US$456.40%no data
0.0021%
Russell Greig
375US$341.90%no data
0.0021%
Marina Wolfson
375US$341.90%no data
0.0016%
SBI Holdings Inc., Asset Management Arm
300US$273.80%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/11 22:24
End of Day Share Price 2025/02/11 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BiomX Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristen KluskaCantor Fitzgerald & Co.
Joseph PantginisH.C. Wainwright & Co.
I-Eh JenLaidlaw & Company (UK) Ltd